Skip to Content


Advisory Committee Information Hotline

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is announcing that we have revised the Advisory Committee Information Hotline (the hotline). The hotline provides the public with access to the most current information available on FDA advisory committee meetings. This notice supersedes all previously published announcements of the hotline.

Start Further Info


Theresa L. Green, Committee Management Officer (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information


The hotline can be accessed by dialing 1-800-741-8138 or 301-443-0572. The advisory committee meeting information and information updates can also be accessed via FDA's advisory committee calendar at​oc/​advisory/​accalendar/​2007/​default.htm.

Each advisory committee is assigned a 10-digit number. This 10-digit number will appear in each individual notice of meeting. The public can obtain information about a particular advisory committee meeting by using the committee's 10-digit number. Information on the hotline is preliminary and may change before a meeting is actually held. The hotline will be updated when such changes are made. The following is a list of each advisory committee's 10-digit number to be used when accessing the hotline.

Advisory Committee10-Digit Access Number
Office of the Commissioner
Pediatric Advisory Committee8732310001
Risk Communication Advisory Committee8732112560
Science Board to the FDA3014512603
Center for Biologics Evaluation and Research
Allergenic Products Advisory Committee3014512388
Blood Products Advisory Committee3014519516
Start Printed Page 31077
Cellular, Tissue & Gene Therapies Advisory Committee3014512389
Transmissible Spongiform Encephalopathies Advisory Committee3014512392
Vaccines and Related Biological Products Advisory Committee3014512391
Center for Drug Evaluation and Research
Anesthetic and Life Support Drugs Advisory Committee3014512529
Anti-Infective Drugs Advisory Committee3014512530
Antiviral Drugs Advisory Committee3014512531
Arthritis Advisory Committee3014512532
Cardiovascular and Renal Drugs Advisory Committee3014512533
Dermatologic and Ophthalmic Drugs Advisory Committee3014512534
Drug Safety and Risk Management Advisory Committee3014512535
Endocrinologic and Metabolic Drugs Advisory Committee3014512536
Gastrointestinal Drugs Advisory Committee3014512538
Nonprescription Drugs Advisory Committee3014512541
Oncologic Drugs Advisory Committee3014512542
Peripheral and Central Nervous System Drugs Advisory Committee3014512543
Pharmaceutical Science & Clinical Pharmacology, Advisory Committee for (formerly Advisory Committee for Pharmaceutical Science)3014512539
Psychopharmacologic Drugs Advisory Committee3014512544
Pulmonary-Allergy Drugs Advisory Committee3014512545
Reproductive Health Drugs, Advisory Committee for3014512537
Center for Food Safety and Applied Nutrition
Food Advisory Committee3014510564
Center for Devices and Radiological Health
Device Good Manufacturing Practice Advisory Committee3014512398
Medical Devices Advisory Committee (composed of 18 panels)
Anesthesiology and Respiratory Therapy Devices Panel3014512624
Circulatory System Devices Panel3014512625
Clinical Chemistry and Clinical Toxicology Devices Panel3014512514
Dental Products Panel3014512518
Ear, Nose, and Throat Devices Panel3014512522
Gastroenterology-Urology Devices Panel3014512523
General and Plastic Surgery Devices Panel3014512519
General Hospital and Personal Use Devices Panel3014512520
Hematology and Pathology Devices Panel3014512515
Immunology Devices Panel3014512516
Medical Devices Dispute Resolution Panel3014510232
Microbiology Devices Panel3014512517
Start Printed Page 31078
Molecular and Clinical Genetics Panel3014510231
Neurological Devices Panel3014512513
Obstetrics-Gynecology Devices3014512524
Ophthalmic Devices Panel3014512396
Orthopaedic and Rehabilitation Devices Panel3014512521
Radiological Devices Panel3014512526
National Mammography Quality Assurance Advisory Committee3014512397
Technical Electronic Product Radiation Safety Standards Committee3014512399
Center for Veterinary Medicine
Veterinary Medicine Advisory Committee3014512548
National Center for Toxicological Research (NCTR)
Science Advisory Board to NCTR3014512559

The hotline will provide the most recent information available on upcoming advisory committee meetings, guidance for making an oral presentation during the open public hearing portion of a meeting, and procedures on obtaining copies of transcripts of advisory committee meetings. Because the hotline will communicate the most current information available about any particular advisory committee meeting, this system will provide interested parties with timely and equal access to such information. The hotline should also conserve agency resources by reducing the current volume of inquiries individual FDA offices and employees must handle concerning advisory committee schedules and procedures.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

Start Signature

Dated: May 28, 2007.

Randall W. Lutter,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. E7-10738 Filed 6-4-07; 8:45 am]